Bausch Health Companies shares are trading higher on continued upward momentum after the company yesterday announced a court ruling in its favor. Also, the company today announced publication of a new clinical study which suggests the use of OraPharma's ARESTIN(R) microspheres, 1mg may decrease certain pathogens in adults with periodontitis.
Portfolio Pulse from Benzinga Newsdesk
Bausch Health Companies shares are trading higher following the publication of a clinical study suggesting that OraPharma's ARESTIN(R) microspheres, 1mg may decrease certain pathogens in adults with periodontitis.
May 18, 2023 | 5:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bausch Health Companies shares are trading higher after a clinical study showed positive results for OraPharma's ARESTIN(R) microspheres in periodontitis treatment.
The positive clinical study results for OraPharma's ARESTIN(R) microspheres suggest a potential new treatment option for periodontitis, which could lead to increased demand for the product and higher revenues for Bausch Health Companies. This news is likely to have a positive short-term impact on BHC's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100